CLDN7 and colorectal cancer: From a clinical point of view, high CLDN2 in colorectal cancer appears to be linked to poor outcome in those receiving 5-FU treatment [22] and CLDN1 and CLDN7 appear to form a claudin signature to predict the clinical response to chemotherapies in colorectal cancer [23].